Health

Health Policy Shifts

Updated 2026-05-11 18:15 UTC 1 source Neutral

President Trump is reconsidering the FDA’s stance on kratom derivatives, potentially allowing some forms of approval. Meanwhile, Medicare data shows lower-than-expected use of Alzheimer's drugs among seniors.

Coverage timeline — 2 articles

STAT News

STAT+: Medicare’s miss on Alzheimer’s drug spending

Far fewer seniors than expected are taking costly Alzheimer's drugs.

2026-05-11 18:03 UTC

STAT News

STAT+: Trump pivots on kratom derivative 7-OH, floating approval for some forms

Last year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump says approval should be considered.

2026-05-11 18:04 UTC